Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.
The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.
An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian found that a self-guided cognitive behavioral therapy app significantly reduced anxiety in young adults struggling with mental health challenges.
While a strain of highly pathogenic avian influenza virus has been detected in dairy cattle in nine states – not including New York state – the commercial milk supply continues to be safe, according to a panel of experts.
A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.
Eating flours, burgers and fitness bars made from crickets, mealworms or black soldier fly larvae could help feed a growing global population sustainably, but it might hit resistance from those who follow halal or kosher regulations.
Specialized nursing facility clinicians, or SNFists, may decrease the likelihood of nursing home residents experiencing stressful hospitalizations and improve the quality of life in their last days, according to researchers from Weill Cornell Medicine.
Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.